STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] Park Ha Biological Technology Co., Ltd. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Park Ha Biological Technology Co., Ltd. announced a change of trading symbol for its ordinary shares to BYAH, from PHH. The Company anticipates the new ticker will become effective on the Nasdaq Stock Market at the open of trading on Monday, October 28, 2025.

The Company also issued a press release about the ticker symbol change, furnished as Exhibit 99.1.

Positive

  • None.

Negative

  • None.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of October 2025

 

Commission File Number: 001-42453

 

Park Ha Biological Technology Co., Ltd.

 

901, Building C, Phase 2

Wuxi International Life Science Innovation Campus

196 Jinghui East Road

Xinwu District, Wuxi, Jiangsu Province

People’s Republic of China 214000

+86 400 012 7562

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F ☒        Form 40-F ☐

 

 

 

 

 

Change of Trading Symbol

 

On October 24, 2025, Park Ha Biological Technology Co., Ltd. (the “Company”) announced a change of trading symbol for its ordinary shares to “BYAH” (from “PHH”), which the Company anticipates will become effective on the Nasdaq Stock Market at the open of trading on Monday October 28, 2025.

 

On October 24, 2025, the Company issued a press release, a copy of which is attached hereto as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K, announcing the ticker symbol change.

 

EXHIBIT INDEX

 

Exhibit No.    
99.1   Press Release

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Park Ha Biological Technology Co., Ltd.
     
Date: October 24, 2025 By: /s/ Xiaoqiu Zhang
  Name:  Xiaoqiu Zhang
  Title: Chief Executive Officer, Chairperson of the Board of Directors

 

 

2

 

 

PHH

NASDAQ:PHH

PHH Rankings

PHH Latest News

PHH Latest SEC Filings

PHH Stock Data

13.04M
32.18M
73.36%
0.39%
2.59%
Household & Personal Products
Consumer Defensive
Link
China
Wuxi